(Q80860599)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15483659%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

title

Availability of pharmacogenomics-based prescribing information in drug package inserts for currently approved drugs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15483659%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15483659%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

Zineh I

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15483659%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Aquilante CL

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15483659%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Beitelshees AL

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15483659%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Beasley BN

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15483659%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Hartzema AG

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15483659%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

publication date

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15483659%20AND%20SRC:MED&resulttype=core&format=json

The Pharmacogenomics Journal

4 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15483659%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15483659%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15483659%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

354-358

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15483659%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.tpj.6500284

4 January 2020

exact match

0 references

cites work

Pharmacogenomics: translating functional genomics into rational therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500284

7 January 2021

Pharmacogenetics: potential for individualized drug therapy through genetics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500284

7 January 2021

Comparison of cytochrome P450 2C9 genotyping methods and implications for the clinical laboratory

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500284

7 January 2021

Hepatitis C virus genotyping: interrogation of the 5' untranslated region cannot accurately distinguish genotypes 1a and 1b

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500284

7 January 2021

Hepatitis C Virus Subtyping by a Core-Envelope 1-Based Reverse Transcriptase PCR Assay with Sequencing and Its Use in Determining Subtype Distribution among Danish Patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500284

7 January 2021

Hepatitis C genotyping by denaturing high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500284

7 January 2021

Determination of HER-2 status and chromosome 17 polysomy in breast carcinomas comparing HercepTest and PathVysion FISH assay.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500284

7 January 2021

A rapid and simple CYP2D6 genotyping assay--case study with the analgetic tramadol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500284

7 January 2021

CYP2D6 poor metabolizer status can be ruled out by a single genotyping assay for the -1584G promoter polymorphism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500284

7 January 2021

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearance.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500284

7 January 2021

Analysis of the two common alpha-1-antitrypsin deficiency alleles PiMS and PiMZ as modifiers of Pseudomonas aeruginosa susceptibility in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500284

7 January 2021

A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500284

7 January 2021

Genotype relationships in the CYP3A locus in Caucasians

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500284

7 January 2021

Cytochrome P450 (CYP) 1A2, sulfotransferase (SULT) 1A1, and N-acetyltransferase (NAT) 2 polymorphisms and susceptibility to urothelial cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500284

7 January 2021

Genetic polymorphism in the 5'-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500284

7 January 2021

Diagnostic testing for Prader-Willi syndrome and Angelman syndrome: a cost comparison

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500284

7 January 2021

Metabolic and neuropsychological phenotype in women heterozygous for ornithine transcarbamylase deficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500284

7 January 2021

Factor IX inhibitors and anaphylaxis in hemophilia B.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500284

7 January 2021

Pharmacogenomics--drug disposition, drug targets, and side effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500284

7 January 2021

Pharmacogenomics: the inherited basis for interindividual differences in drug response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500284

7 January 2021

Pharmacogenomics in Drug Development and Regulatory Decision-making: the Genomic Data Submission (GDS) Proposal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500284

7 January 2021

Inheritance and drug response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500284

7 January 2021

The thiopurine S-methyltransferase gene locus -- implications for clinical pharmacogenomics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500284

7 January 2021

Pharmacogenetics of cancer therapy: getting personal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500284

7 January 2021

Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500284

7 January 2021

Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500284

7 January 2021

Association of pharmacokinetic (CYP2C9) and pharmacodynamic (factors II, VII, IX, and X; proteins S and C; and gamma-glutamyl carboxylase) gene variants with warfarin sensitivity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500284

7 January 2021

CYP2C9 genotypes and dose requirements during the induction phase of oral anticoagulant therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500284

7 January 2021

CYP2C9 and oral anticoagulation therapy with acenocoumarol and warfarin: similarities yet differences

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500284

7 January 2021

Pharmacogenomics: implications for laboratory medicine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500284

7 January 2021

Assessing the cost-effectiveness of pharmacogenomics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500284

7 January 2021